Cobus Loots, CEO of Pan African Resources, on delivering sector-leading returns for shareholders. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksGenedrive Regulatory News (GDR)

Share Price Information for Genedrive (GDR)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 1.70
Bid: 1.60
Ask: 1.80
Change: 0.00 (0.00%)
Spread: 0.20 (12.50%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 1.65
GDR Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Total Voting Rights

1 Feb 2021 07:00

RNS Number : 4282N
Genedrive PLC
01 February 2021
 

 

 

genedrive plc

("genedrive" or the "Company")

 

 

 

Total Voting Rights

 

Genedrive plc (AIM: GDR) notifies the market that as at 31 January 2021 the Company's issued share capital comprises 63,282,548 ordinary shares with voting rights ('Shares'). No Shares are held in Treasury. As such, the number of Shares with voting rights is 63,282,548.

 

This figure may be used by shareholders (and others with notifiable obligations) as their denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Company under the FCA's Disclosure and Transparency Rules.

 

 

genedrive plc

+44 (0)161 989 0245

David Budd: CEO / Matthew Fowler: CFO

Peel Hunt LLP (Nominated Adviser and Joint Broker)

+44 (0)20 7418 8900

James Steel / Oliver Jackson

finnCap (Joint Broker)

+44 (0)20 7220 0500

Geoff Nash / Kate Bannatyne / Alice Lane

Walbrook PR Ltd (Media & Investor Relations)

+44 (0)20 7933 8780 or genedrive@walbrookpr.com

Paul McManus / Anna Dunphy

+44 (0)7980 541 893 / +44 (0)7876 741 001

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TVRDKCBDABKDBDB
Date   Source Headline
17th Dec 20126:13 pmRNSDirector/PDMR Shareholding
13th Dec 20123:24 pmRNSResult of AGM
10th Dec 20129:45 amRNSHolding(s) in Company
7th Dec 20121:00 pmRNSCash Placing
21st Nov 20128:18 amRNSAnnual Report & Accounts and Notice of AGM
25th Oct 201210:54 amRNSHolding(s) in Company
24th Oct 201212:19 pmRNSHolding(s) in Company
24th Oct 20129:51 amRNSHolding(s) in Company
16th Oct 20127:00 amRNSFinal Results
4th Oct 20123:55 pmRNSDirector/PDMR Shareholding
10th Sep 20123:19 pmRNSPreliminary Results Date
6th Aug 20127:00 amRNSPre-Close Trading Update
3rd Aug 201211:58 amRNSProfessor Chris Potten
27th Jul 20124:09 pmRNSDirector's Shareholding and Additional Listing
10th Jul 20129:17 amRNSDirector/PDMR Shareholding
5th Jul 20127:00 amRNSTuberculosis test gains CE-IVD registration
3rd Apr 20124:53 pmRNSDirector/PDMR Shareholding
27th Mar 20129:13 amRNSAdditional Listing
14th Mar 20127:00 amRNSHalf Yearly Report
5th Mar 20127:00 amRNSEpistem Signs TB Channel Partner Agreement
22nd Feb 20128:18 amRNSHolding(s) in Company
21st Feb 20127:00 amRNSNotice of Results
20th Feb 20126:28 pmRNSHolding(s) in Company
10th Feb 20127:00 amRNSHolding(s) in Company
10th Jan 20121:18 pmRNSDirector/PDMR Shareholding
19th Dec 20115:54 pmRNSDirectors' shareholdings and issue of equity
25th Nov 201112:00 pmRNSCash Placing
9th Nov 20117:00 amRNS2011 Annual Report and Accounts & Notice of AGM
11th Oct 20117:00 amRNSFinal Results
7th Oct 201112:43 pmRNSDirector/PDMR Shareholding
5th Oct 20117:00 amRNSHuman DNA Identification Collaboration
27th Sep 20117:00 amRNSGenedriveT passes first in-field Tuberculosis test
4th Aug 20117:00 amRNSPre Close Trading Update
30th Jun 201112:00 pmRNSDirector/PDMR Shareholding
28th Jun 20117:00 amRNSTuberculosis Diagnostic Collaboration
23rd Jun 20114:38 pmRNSHolding(s) in Company
19th May 20115:20 pmRNSHolding(s) in Company
19th Apr 201112:32 pmRNSHolding(s) in Company
19th Apr 201112:28 pmRNSHolding(s) in Company
8th Apr 20119:20 amRNSHolding(s) in Company
5th Apr 20112:34 pmRNSDirector/PDMR Shareholding
4th Apr 201112:41 pmRNSHolding(s) in Company
4th Apr 20119:35 amRNSHolding(s) in Company
29th Mar 20117:00 amRNSDirector/PDMR Shareholding
29th Mar 20117:00 amRNSInterim Results
28th Mar 20119:47 amRNSHolding(s) in Company
17th Mar 20119:23 amRNSRe Agreement - Replacement
17th Mar 20117:20 amRNSRe Agreement
28th Feb 20111:22 pmRNSInterim Results Announcement
18th Feb 20114:26 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.